Global Budesonide Sales Market Report 2020

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
The industry's leading manufacturers are AstraZeneca and Teva, with 52.93% and 16.78% of revenue, respectively. By region, North America has the highest share of income, at around 36.5% in 2019.

Market Analysis and Insights: Global Budesonide Market
The global Budesonide market size is projected to reach US$ 9809.2 million by 2026, from US$ 8073 million in 2020, at a CAGR of 3.3% during 2021-2026.

Global Budesonide Scope and Market Size
The global Budesonide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Budesonide market is segmented into
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule

Segment by Application, the Budesonide market is segmented into
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others

The Budesonide market is analysed and market size information is provided by regions (countries). Segment by Application, the Budesonide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Budesonide Market Share Analysis
Budesonide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Budesonide business, the date to enter into the Budesonide market, Budesonide product introduction, recent developments, etc.

The major vendors covered:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod